Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
CALL
Tapestry
TPR
$26B
| $11.7M | 0.04% |
165,700
+134,300
| +428% | +$10.2M |
|
402
Fabrinet
FN
$15.6B
| $11.6M | 0.04% |
58,853
-40,013
| -40% | -$8.73M |
|
403
ARK Innovation ETF
ARKK
$6.72B
| $11.6M | 0.04% |
244,043
+226,050
| +1,256% | +$13M |
|
404
The Mosaic Company
MOS
$7.76B
| $11.6M | 0.04% |
428,626
+349,870
| +444% | +$9.25M |
|
405
PUT
W.W. Grainger
GWW
$61.8B
| $11.6M | 0.04% |
11,700
+8,500
| +266% | +$8.79M |
|
406
Williams-Sonoma
WSM
$28B
| $11.5M | 0.04% |
+72,747
| New | +$14.1M |
|
407
CALL
Eli Lilly
LLY
$1.12T
| $11.5M | 0.04% |
13,900
-29,400
| -68% | -$24.5M |
|
408
CALL
Brinker International
EAT
$10.6B
| $11.4M | 0.04% |
76,800
+51,100
| +199% | +$7.86M |
|
409
New York Times
NYT
$10.6B
| $11.4M | 0.04% |
230,686
-13,399
| -5% | -$674K |
|
410
Darling Ingredients
DAR
$10.4B
| $11.4M | 0.04% |
+364,113
| New | +$12.7M |
|
411
PUT
Reddit
RDDT
$29.5B
| $11.4M | 0.04% |
108,300
+93,000
| +608% | +$15.4M |
|
412
PUT
Constellation Brands
STZ
$23.2B
| $11.4M | 0.04% |
61,900
+51,700
| +507% | +$9.39M |
|
413
Hims & Hers Health
HIMS
$7.88B
| $11.3M | 0.04% |
382,568
+229,551
| +150% | +$8.53M |
|
414
CALL
Northrop Grumman
NOC
$78.3B
| $11.3M | 0.04% |
+22,000
| New | +$10.5M |
|
415
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $11.1M | 0.04% |
17,500
-500
| -3% | -$344K |
|
416
CALL
KKR & Co
KKR
$97.4B
| $11.1M | 0.04% |
96,000
+4,400
| +5% | +$605K |
|
417
PUT
Dollar Tree
DLTR
$25.3B
| $11M | 0.04% |
146,000
-220,200
| -60% | -$15.7M |
|
418
Stryker
SYK
$126B
| $10.9M | 0.04% |
29,358
+10,563
| +56% | +$4.02M |
|
419
iShares China Large-Cap ETF
FXI
$4.28B
| $10.9M | 0.04% |
304,603
-78,710
| -21% | -$2.66M |
|
420
CALL
Netflix
NFLX
$331B
| $10.9M | 0.04% |
117,000
-181,000
| -61% | -$17.2M |
|
421
PTC
PTC
$16.8B
| $10.9M | 0.04% |
+70,283
| New | +$12.1M |
|
422
PJT Partners
PJT
$4.47B
| $10.9M | 0.04% |
78,893
+44,988
| +133% | +$7.08M |
|
423
Vanguard Health Care ETF
VHT
$19.7B
| $10.9M | 0.04% |
+41,089
| New | +$10.9M |
|
424
Old Republic International
ORI
$10B
| $10.8M | 0.04% |
275,458
+43,176
| +19% | +$1.58M |
|
|
CWAN
425
DELISTED
Clearwater Analytics
CWAN
| $10.7M | 0.04% |
400,939
+272,073
| +211% | +$7.64M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.